Cough | Page 10 of 25 | SpiritIndia.com

Rheumatoid Arthritis :: ORENCIA, abatacept demonstrate continued efficacy in adults with rheumatoid arthritis

Bristol-Myers Squibb Company (NYSE: BMY) today announced that two-year data from three Phase III pivotal trials demonstrate the long-term efficacy of ORENCIA? (abatacept) in adult patients with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs (DMARDs) such as methotrexate and TNF antagonists. The data also demonstrate that ORENCIA provided clinically meaningful improvements in multiple aspects of health-related quality of life and physical function, sustained improvements in pain and had a consistent safety and tolerability profile through two years of treatment. These data will be presented at the upcoming 2006 American College of Rheumatology (ACR) Annual Scientific Meeting.

Smoking :: Mayo Clinic Tests New Drug to Help Smokers Quit

The Mayo Clinic Nicotine Research Program is conducting a research study to help smokers who would like to quit. The study will test whether the drug Chantix (varenicline) helps smokers who have Chronic Obstructive Pulmonary Disease (COPD) stop smoking.

Health :: Enterovirus – 71 case confirmed

The Centre for Health Protection has confirmed another enterovirus-71 case involving an 18-month-old boy, bringing the year’s total to 15.

Cystic Fibrosis :: Newly discovered proteins associated with cystic fibrosis

Researchers have found a highly unusual distribution of two proteins in the lungs and airways of people with cystic fibrosis, a discovery that could be a step in determining how the disease progresses. The proteins, first uncovered as a result of the human genome project, are thought to play a role in the body’s immune system.

Tuberculosis :: Cases of Tuberculosis rise steeply during 2005

Cases of Tuberculosis (TB) in England, Wales and Northern Ireland have increased by 10.8% from 7,321 cases reported in 2004 to 8,113 in 2005 according to new figures released today by the Health Protection Agency.

Lung Cancer :: Minister launches Lung Cancer Awareness Month

To highlight the symptoms of lung cancer health minister Rosie Winterton today launched Lung Cancer Awareness Month at the Royal Mail’s South London Mail Centre, where she heard first hand the experiences of lung cancer patients and met representatives from Royal Mail, the voluntary sector and health professionals.

Hepatitis :: Bristol-Myers Squibb’s Baraclude, entecavir suppressed viral load to undetectable levels

Bristol-Myers Squibb Company (NYSE: BMY) announced data from a three-year cohort (ETV-022/901, n=119), which showed BARACLUDE? (entecavir) suppressed viral load to undetectable levels in 90 percent of nucleoside-na?ve chronic hepatitis B e-antigen (HBeAg) positive patients at week 144 who continued on-treatment from week 96. In this cohort, undetectable HBV DNA levels were defined as less than 300 copies per mL of blood as measured by polymerase chain reaction (PCR). Suppression of viral load to undetectable levels is one of several measures of antiviral treatment response; a sustained, undetectable viral load is an important goal of chronic hepatitis B treatment. The results of this three-year cohort were presented today at the 57th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD).

Flu :: Cognis Targets Cold, Flu Season with Arsenal of Immunity-Enhancing Ingredients

A compromised immune system makes people more prone to contracting a cold or flu, and Cognis is helping companies meet the growing demand worldwide for immunity boosting dietary supplements and functional foods. Colds and flu are the most frequent infections across all age groups. Each year, Americans suffer from one billion colds, 100,000 are hospitalized and about 36,000 die from the flu and its complications. Immune health is also a global concern with frequent colds and flu ranked as one of the top three health problems by consumers in China, India and Latin America.

Influenza :: Good medicines for flu, influenza in alternative medicines

“Friends, as the winters are coming, they are bringing influenza with them. So, be prepared to fight the disease and know about it,” Dr. Poonam Singhal. Influenza, also called grippe or flu, an acute contagious viral infection characterized by inflammation of the respiratory tract and by fever, chills, muscular pain, and prostration, with cough, cold, sneezings, intense frontal headache, pain and aches in joints, fever (100 deg. F to 105 deg. F), nausea, etc.

ADHD :: Lilly’s Strattera, atomoxetine effective in treating ADHD in children and adolescents

New data suggest that Strattera? (atomoxetine HCl) improved ADHD symptoms in children and adolescents who had both ADHD and a reading disorder, like dyslexia. Results were announced at a meeting of child and adolescent psychiatrists.